CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock Common Class A	Additional paid in capital	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021		81,211,781
Beginning balance at Dec. 31, 2021	$ 131,888	$ 1	$ 340,570	$ (208,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		170,751
Issuance of common stock upon exercise of stock options	48		48
Issuance of common stock upon vesting of RSUs (in shares)		113,710
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)		(18,673)
Share repurchase related to Section 16 Officer tax coverage exchange	(59)		(59)
Stock-based compensation - stock options, RSAs, RSUs	2,212		2,212
Share repurchase	(6,000)		(6,000)
Shares issued upon exercise of warrant (in shares)		278,146
Net loss	(26,834)			(26,834)
Ending balance (in shares) at Mar. 31, 2022		81,755,715
Ending balance at Mar. 31, 2022	$ 101,255	$ 1	336,771	(235,517)
Beginning balance (in shares) at Dec. 31, 2022	84,441,153	84,441,153
Beginning balance at Dec. 31, 2022	$ 38,607	$ 1	342,733	(304,127)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	370,287	370,287
Issuance of common stock upon exercise of stock options	$ 92		92
Issuance of common stock upon vesting of RSUs (in shares)		766,791
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)		(124,899)
Share repurchase related to Section 16 Officer tax coverage exchange	(60)		(60)
Stock-based compensation - stock options, RSAs, RSUs	1,720		1,720
Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares)		9,396,000
Issuance of common stock and related warrants in registered offering, net of issuance costs	9,300		9,300
Issuance of common stock to non-employees (in shares)		135,000
Issuance of common stock to non-employees	112		112
Net loss	$ (20,825)			(20,825)
Ending balance (in shares) at Mar. 31, 2023	94,984,332	94,984,332
Ending balance at Mar. 31, 2023	$ 28,946	$ 1	$ 353,897	$ (324,952)